Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 9/2005

01-09-2005 | Original Paper

Reduction of drug leakage by negative-balance isolated pelvic perfusion: correlation between leakage and in-out flow rate in a pig model

Authors: Satoru Murata, Hiroyuki Tajima, Gen-ichi Kusakai, Tatsuo Kumazaki, Yutaka Abe, Shiro Onozawa, Yasushige Komada, Yukihiro Kondo, Ryoji Kimata, Seiichiro Himeno, Mitsuo Satake

Published in: Journal of Cancer Research and Clinical Oncology | Issue 9/2005

Login to get access

Abstract

Purpose: Isolated pelvic perfusion (IPP) therapy exposes target tissues to high doses of anticancer drugs with low systemic concentrations, but the major drawback is drug leakage into the systemic circulation, which often thwarts the increased drug concentration. In this study, the efficacy of altering the in-out flow rate during IPP in order to decrease the leakage was assessed in adult pigs. Methods: The abdominal aorta and the infrarenal vena cava were occluded with two balloon catheters, blood in the extracorporeal circuit was circulated with twin rotary pumps, and the IPP was performed with platinum. Three sets of in-out flow rates were used, and the degree of drug leakage into the systemic circulation was evaluated. The volume of blood withdrawn was equal to the volume returned (300 ml/min; group A), 5% higher (group B), or 10% higher (group C). The platinum concentrations in the pelvic circulation, systemic circulation, and urine were measured and compared. Results: The average and maximum plasma platinum concentrations in the pelvic circulation did not significantly differ among the three groups. The plasma platinum concentrations in the systemic venous circulation of the three groups significantly (P<0.01) decreased as the volume withdrawn during IPP increased. The percentage of platinum eliminated in the urine during IPP was significantly (P<0.01) lower in group B and C than in group A. Conclusions: Setting the volume withdrawn higher than the volume returned decreased leakage into the systemic circulation under isolated pelvic perfusion.
Literature
go back to reference Austen WA, Monaco AP, Richardson GS, Baker WH, Shaw RS, Raker JW (1959) Treatments of malignant pelvic tumors by extracorporeal perfusion with chemotherapeutic agents. N Engl J Med 261:1037–1045PubMedCrossRef Austen WA, Monaco AP, Richardson GS, Baker WH, Shaw RS, Raker JW (1959) Treatments of malignant pelvic tumors by extracorporeal perfusion with chemotherapeutic agents. N Engl J Med 261:1037–1045PubMedCrossRef
go back to reference Collins JM (1989) Pharmacologic rationale for regional drug delivery. J Clin Oncol 2:498–504 Collins JM (1989) Pharmacologic rationale for regional drug delivery. J Clin Oncol 2:498–504
go back to reference Creech O, Krementz ET, Ryan RF, Winblad JN (1958) Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 148:616–632PubMedCrossRef Creech O, Krementz ET, Ryan RF, Winblad JN (1958) Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 148:616–632PubMedCrossRef
go back to reference Guadagni S, Aigner KR, Palumbo G, Cantore M, Fiorentini G, Pozone T, Deraco M, Clerico M, Chaudhuri PK (1998) Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancer. J Clin Pharmacol 38(10):936–44PubMed Guadagni S, Aigner KR, Palumbo G, Cantore M, Fiorentini G, Pozone T, Deraco M, Clerico M, Chaudhuri PK (1998) Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancer. J Clin Pharmacol 38(10):936–44PubMed
go back to reference Lawrence W Jr, Kuehn P, Mori S (1961) Regional perfusion of the pelvis: considerations of the leakage problem. Surgery 50:248–259PubMed Lawrence W Jr, Kuehn P, Mori S (1961) Regional perfusion of the pelvis: considerations of the leakage problem. Surgery 50:248–259PubMed
go back to reference Lawrence W Jr, Clarkson B, Kim M, Clapp P, Randall HT (1963) Regional perfusion of pelvis and abdomen by an indirect technique. Cancer 16:567–582CrossRef Lawrence W Jr, Clarkson B, Kim M, Clapp P, Randall HT (1963) Regional perfusion of pelvis and abdomen by an indirect technique. Cancer 16:567–582CrossRef
go back to reference Lingareddy V, Ahmad NR, Mohinddin M (1997) Palliative reiradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys 38:785–790CrossRefPubMed Lingareddy V, Ahmad NR, Mohinddin M (1997) Palliative reiradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys 38:785–790CrossRefPubMed
go back to reference Shingleton WW, Parker RT, Mahaley S (1961) Abdominal perfusion for cancer chemotherapy with hypothermia and hyperthermia. Surgery 50:260–265 Shingleton WW, Parker RT, Mahaley S (1961) Abdominal perfusion for cancer chemotherapy with hypothermia and hyperthermia. Surgery 50:260–265
go back to reference Stehlin JS, Clark RL, White EC (1960) Regional chemotherapy for cancer: experience with 116 perfusions. Ann Surg 151:605–619PubMedCrossRef Stehlin JS, Clark RL, White EC (1960) Regional chemotherapy for cancer: experience with 116 perfusions. Ann Surg 151:605–619PubMedCrossRef
go back to reference Turk PS, Belliveau JF, Darnowski JW, Weinberg MC, Leenen L, Wanebo HJ (1993) Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. Arch Surg 128:533–539PubMed Turk PS, Belliveau JF, Darnowski JW, Weinberg MC, Leenen L, Wanebo HJ (1993) Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. Arch Surg 128:533–539PubMed
go back to reference Wanebo HJ, Belliveau JF (1999) A pharmacokinetic model and clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion. Cancer Chemother Pharmacol 43:427–434CrossRefPubMed Wanebo HJ, Belliveau JF (1999) A pharmacokinetic model and clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion. Cancer Chemother Pharmacol 43:427–434CrossRefPubMed
go back to reference Wanebo HJ, Chung MD, Levy AI, Turk PS, Vezeridis MP, Belliveau JF (1996) Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon occlusion technique. Ann Surg Oncol 3:295–303PubMedCrossRef Wanebo HJ, Chung MD, Levy AI, Turk PS, Vezeridis MP, Belliveau JF (1996) Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon occlusion technique. Ann Surg Oncol 3:295–303PubMedCrossRef
go back to reference Watkins E Jr, Hering AC, Luna R, Adams HD (1960) The use of intravascular balloon catheters for isolation of the pelvic bed during pump oxygenerator perfusion of cancer chemotherapeutic agents. Surg Gynecol Obstet 111:464–468PubMed Watkins E Jr, Hering AC, Luna R, Adams HD (1960) The use of intravascular balloon catheters for isolation of the pelvic bed during pump oxygenerator perfusion of cancer chemotherapeutic agents. Surg Gynecol Obstet 111:464–468PubMed
go back to reference Wile AG, Smolin M (1987) Hyperthermic pelvic isolation-perfusion in the treatment of refractory pelvic cancer. Arch Surg 122:1321–1325PubMed Wile AG, Smolin M (1987) Hyperthermic pelvic isolation-perfusion in the treatment of refractory pelvic cancer. Arch Surg 122:1321–1325PubMed
go back to reference Wile AG, Stemmer EA, Andrews PA, Murphy MP, Abramson IS, Howell SB (1985) Pharmacokinetics of 5-fluorouracil during hyperthermic pelvic isolation-perfusion. J Clin Oncol 3:849–852PubMed Wile AG, Stemmer EA, Andrews PA, Murphy MP, Abramson IS, Howell SB (1985) Pharmacokinetics of 5-fluorouracil during hyperthermic pelvic isolation-perfusion. J Clin Oncol 3:849–852PubMed
go back to reference Wong CS, Cummings BJ, Brierley JD, Catton CN, McLean M, Catton P, Hao Y (1998) Treatment of locally recurrent rectal carcinoma: results and prognostic factors. Int J Radiat Oncol Biol Phys 40:427–435CrossRefPubMed Wong CS, Cummings BJ, Brierley JD, Catton CN, McLean M, Catton P, Hao Y (1998) Treatment of locally recurrent rectal carcinoma: results and prognostic factors. Int J Radiat Oncol Biol Phys 40:427–435CrossRefPubMed
Metadata
Title
Reduction of drug leakage by negative-balance isolated pelvic perfusion: correlation between leakage and in-out flow rate in a pig model
Authors
Satoru Murata
Hiroyuki Tajima
Gen-ichi Kusakai
Tatsuo Kumazaki
Yutaka Abe
Shiro Onozawa
Yasushige Komada
Yukihiro Kondo
Ryoji Kimata
Seiichiro Himeno
Mitsuo Satake
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 9/2005
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-004-0666-4

Other articles of this Issue 9/2005

Journal of Cancer Research and Clinical Oncology 9/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.